首页 | 本学科首页   官方微博 | 高级检索  
     

更昔洛韦防治异基因骨髓移植巨细胞病毒感染
引用本文:赵恒,邬国和,颜丽华,李东宁,李萍. 更昔洛韦防治异基因骨髓移植巨细胞病毒感染[J]. 实用临床医学(江西), 2005, 6(8): 24-25
作者姓名:赵恒  邬国和  颜丽华  李东宁  李萍
作者单位:江西医学院第三附属医院血液科 江西南昌330008(赵恒,邬国和,颜丽华,李东宁),江西医学院第三附属医院血液科 江西南昌330008(李萍)
摘    要:目的探讨更昔洛韦防治异基因骨髓移植(alloBMT)术后巨细胞病毒(CMV)感染的临床效果。方法对6例alloBMT病人使用更昔洛韦防治CMV感染,预防用药,更昔洛韦5mg/(kg·次),q12h,于术前-9~-1d使用;治疗用药,更昔洛韦5mg/(kg·次),q12h,14~21d,而后每周用药5d维持2~3周。结果6例alloBMT患者术后有3例出现CMV感染,均治愈,随访3~9个月未再出现CMV感染。结论更昔洛韦防治异基因造血干细胞移植术后CMV感染效果良好,早期诊断和治疗更为重要。

关 键 词:更昔洛韦  巨细胞病毒  感染  异基因骨髓移植
文章编号:1009-8194(2005)08-0024-02
修稿时间:2005-04-21

The Effect of Ganciclovir on Prevention and Treatment of CMV Infection after Allo-BMT
Zhao Heng,WU Guo-he,Yan Li-hua,Li Dong-ling,Li Ping. The Effect of Ganciclovir on Prevention and Treatment of CMV Infection after Allo-BMT[J]. Practical Clinical Medicine, 2005, 6(8): 24-25
Authors:Zhao Heng  WU Guo-he  Yan Li-hua  Li Dong-ling  Li Ping
Abstract:Objective:To probe the clinical effect of ganciclovir(GCV) on prevention and treatment of cytomegalovirus (CMV) infection after allogenic bone marrow transplantation (allo-BMT).Methods: Six allo-BMT patients was observed.As preventive medication,each patient was treated with GCV at 5 mg/kg/q12 h from day 9 to day 1 before allo-BMT; as therapeutic medication, each patient who was infected by CMV was treated with GCV at 5 mg/kg/q12 h for 14 to 21 day, then 5 days per week for 2 to 3 weeks sequentially.Results:Three patients were infected by CMV among 6 patients and were cured by GCV. There was no new CMV infection for the next 3 to 9 months with followed-up visit.Conclusion:GCVshows good effect on prevention and treatment of CMV infection after allo-BMT, and an early diagnoses and early treatment is more important.
Keywords:ganciclovir  cytomegalovirus  infection  allogenic bone marrow transplantation
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号